Serial ANCA testing has limited value during the follow-up of disease activity in patients with ANCA-associated vasculitis

Sarcoidosis Vasculitis and Diffuse Lung Disease

Volumn 13, Issue 3, 1996, Pages 246-248

  Lesavre, P ^a   Kyndt, X ^b   Vanhille, P ^b   Reumaux, D ^b   Guillevin, L ^c   Noel L H ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b CENTRE HOSPITALIER DE VALENCIENNES   (France)

^c AVICENNE HOSPITAL   (France)

Author keywords

ANCA testing; Vasculitis

Indexed keywords

AUTOANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOSUPPRESSIVE AGENT; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ANTIBODY TITER; CHURG STRAUSS SYNDROME; DISEASE ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FOLLOW UP; GLOMERULONEPHRITIS; HUMAN; IMMUNOFLUORESCENCE; LUNG HEMORRHAGE; POLYARTERITIS NODOSA; PRIORITY JOURNAL; RELAPSE; SHORT SURVEY; VASCULITIS;

ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; HUMANS; MONITORING, IMMUNOLOGIC; VASCULITIS;

EID: 0029742470     PISSN: 11240490     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (11)

1. Falk R J and Jennette J C: Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med 1988; 318; 1651-1657.
2. van der Woude F J Rasmussen N, Lobatto S et al: Autoantibodies to neutrophils and monocytes: a new tool for diagnosis and a marker of disease activity in Wegener's granulomatosis. Lancet 1935; ii: 425-429.
3. Cohen Tervaert J W, Huitema M G, Hene R J et al: Prevention of relapses in Wegener's granulomatosis by treatment based on antineutrophil cytoplasmic antibody titre. Lancet 1990; 336: 709-711.
4. Pettersson E and Helgl Z: Antineutrophil cytoplasmic antibody (cANCA and pANCA) titers in relation to disease activity in patients with necrotizing vasculitis: a longitudinal study. Clin Nephrol 1992; 37: 219-228.
5. De'Oliviera J, Gaskin G, Dash A, Rees A J and Pusey C D: Relationship between disease activity and anti-neutrophil cytoplasmic antibody concentration in long-term management of systemic vasculitis. Am J Kidney Dis 1995; 25: 380-389.
6. Jayne D R W, Gaskin G, Pusey C D and Lockwood C M: ANCA and predicting relapse in systematic vasculitis. Q J Med 1995; 88: 127-133.
7. Kerr G S, Fleisher T A, Hallahan C W, Leavitt R Y, Fauci A S and Hoffman G S: Limited prognostic value of changes in antineutophil cytoplasmic antibody titers in patients with Wegener's granulomatosis. Adv Exp Med Biol 1993; 336: 411-414.
8. Geffriaud-Ricouard C, Noël L H, Chauveau D, Houhou S, Grünfeld J P and Lesavre P: Clinical spectrum associated with ANCA of defined antigen specificities in 98 selected patients. Clin Nephrol 1993; 39: 125-136.
9. Cohen P, Guillevin L, Baril L, Lhote F, Noël L H and Lesavre P: Persistence of antineutrophil cytoplasmic antibodies (ANCA) in asymptomatic patients with systemic polyarteritis nodosa or Churg-Strauss syndrome: Follow-up of 53 patients. Clin Exp Rheumatol 1995; 13: 193-193.
10. Kokolina E, Noël L H, Nusbaum P et al: Isotype and affinity on anti-myeloperoxidase autoantibodics in systemic vasculitis. Kidney Int 1994; 46: 177-184.
11. Morin M P, Thervet E, Legendre C, Page B, Kreis H and Noël L H: Successful kidney transplantation in a patient with microscopic polyarteritis and positive ANCA. Nephrol Dial Transplant 1993; 8: 287-288.